Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.81)
# 1,674
Out of 5,123 analysts
26
Total ratings
62.5%
Success rate
19%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $478.93 | -28.17% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $20.51 | +160.85% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $27.76 | +44.09% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $41.56 | -27.82% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $7.00 | +21.43% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $21.60 | -25.93% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.12 | +50,418.87% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $340 → $460 | $1.05 | +43,919.14% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $7.72 | +560.62% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $35.70 | -55.18% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $6.50 | +592.31% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $478.93
Upside: -28.17%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $20.51
Upside: +160.85%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $27.76
Upside: +44.09%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $41.56
Upside: -27.82%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $7.00
Upside: +21.43%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $21.60
Upside: -25.93%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.12
Upside: +50,418.87%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $340 → $460
Current: $1.05
Upside: +43,919.14%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $7.72
Upside: +560.62%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $35.70
Upside: -55.18%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $6.50
Upside: +592.31%